Works matching IS 00099104 AND DT 2020 AND VI 201 AND IP 3

Results: 12

B(effector)reaking bad in systemic sclerosis: role of a novel B cell subset.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 231, doi. 10.1111/cei.13501
By:
- O'Reilly, S.;
- Laar, J.
Publication type:
Article
Generation of a novel CD30<sup>+</sup> B cell subset producing GM‐CSF and its possible link to the pathogenesis of systemic sclerosis.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 233, doi. 10.1111/cei.13477
By:
- Higashioka, K.;
- Kikushige, Y.;
- Ayano, M.;
- Kimoto, Y.;
- Mitoma, H.;
- Kikukawa, M.;
- Akahoshi, M.;
- Arinobu, Y.;
- Horiuchi, T.;
- Akashi, K.;
- Niiro, H.
Publication type:
Article
Complement activation in patients with immune thrombocytopenic purpura according to phases of disease course.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 258, doi. 10.1111/cei.13475
By:
- Castelli, R.;
- Lambertenghi Delilliers, G.;
- Gidaro, A.;
- Cicardi, M.;
- Bergamaschini, L.
Publication type:
Article
Late diagnosis of chronic granulomatous disease.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 297, doi. 10.1111/cei.13474
By:
- Barkai, T.;
- Somech, R.;
- Broides, A.;
- Gavrieli, R.;
- Wolach, B.;
- Marcus, N.;
- Hagin, D.;
- Stauber, T.
Publication type:
Article
Cladribine modifies functional properties of microglia.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 328, doi. 10.1111/cei.13473
By:
- Jørgensen, L. Ø.;
- Hyrlov, K. H.;
- Elkjaer, M. L.;
- Weber, A. B.;
- Pedersen, A. E.;
- Svenningsen, Å. Fex;
- Illes, Z.
Publication type:
Article
Hypomethylation of Notch1 DNA is associated with the occurrence of uveitis.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 317, doi. 10.1111/cei.13471
By:
- Wei, H.;
- Yin, X.;
- Tang, H.;
- Gao, Y.;
- Liu, B.;
- Wu, Q.;
- Tian, Q.;
- Hao, Y.;
- Bi, H.;
- Guo, D.
Publication type:
Article
HBV‐specific CD8 T cells present higher TNF‐α expression but lower cytotoxicity in hepatocellular carcinoma.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 289, doi. 10.1111/cei.13470
By:
- Zhao, L.;
- Jin, Y.;
- Yang, C.;
- Li, C.
Publication type:
Article
Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 306, doi. 10.1111/cei.13469
By:
- Bontempi, I.;
- Leal, K.;
- Prochetto, E.;
- Díaz, G.;
- Cabrera, G.;
- Bortolotti, A.;
- Morbidoni, H. R.;
- Borsuk, S.;
- Dellagostin, O.;
- Marcipar, I.
Publication type:
Article
Peptidoglycan‐treated tumor antigen‐pulsed dendritic cells impart complete resistance against tumor rechallenge.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 279, doi. 10.1111/cei.13468
By:
- Patidar, A.;
- Selvaraj, S.;
- Chauhan, P.;
- Guzman, C. A.;
- Ebensen, T.;
- Sarkar, A.;
- Chattopadhyay, D.;
- Saha, B.
Publication type:
Article
Suppressed immune profile in children with combined type 1 diabetes and celiac disease.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 244, doi. 10.1111/cei.13454
By:
- Tompa, A.;
- Åkesson, K.;
- Karlsson, S.;
- Faresjö, M.
Publication type:
Article
Immunorelated gene polymorphisms associated with acute myeloid leukemia.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 266, doi. 10.1111/cei.13446
By:
- Liu, Q.;
- Hua, M.;
- Yan, S.;
- Zhang, C.;
- Wang, R.;
- Yang, X.;
- Han, F.;
- Hou, M.;
- Ma, D.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2020, v. 201, n. 3, p. 1, doi. 10.1111/cei.13325
Publication type:
Article